Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation
- 5 March 2009
- journal article
- research article
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 25 (3) , 175-181
Abstract
Aggressive anticoagulation with heparin to maintain an activated clotting time (ACT) >300 s is required during catheter ablation of atrial fibrillation (AF) to reduce the risk of systemic thromboembolism. The purpose of this study is to describe the incidence and outcome of protamine reactions and analyze the risk factors in patients undergoing catheter ablation of AF.Keywords
This publication has 19 references indexed in Scilit:
- Anaphylaxis During Cardiac Surgery: Implications for CliniciansAnesthesia & Analgesia, 2008
- HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-UpHeart Rhythm, 2007
- Incidence and Time Course of Early Recovery of Pulmonary Vein Conduction after Catheter Ablation of Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2007
- The diagnosis and management of anaphylaxis: An updated practice parameterJournal of Allergy and Clinical Immunology, 2005
- Allergy to protamine sulfateHeart & Lung, 1999
- Protamine allergy reactions during cardiac catheterization and cardiac surgery: Risk in patients taking protamine‐insulin preparationsCatheterization and Cardiovascular Diagnosis, 1991
- A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgeryJournal of Allergy and Clinical Immunology, 1990
- The safety of protamine sulfate in diabetics undergoing cardiac catheterizationCatheterization and Cardiovascular Diagnosis, 1987
- ProtamineAnesthesia & Analgesia, 1985
- Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization.Circulation, 1984